GPT and metabolic dysfunction-associated steatotic liver disease: The meta-analysis finally concluded from the perspective of three outcome indicators, HBV-conversion, ALT-normalization, and HBeAg conversion, that CHB patients with NAFLD had lower efficacy than CHB patients after 48 weeks of antiviral therapy with nucleoside analogs.